Products > Catalog Antibodies > Monoclonal Antibodies

SARS-COV-2 Neutralizing Antibody (A19215)

Datasheet

ABclonal:SDS-PAGE
ABclonal:Bioactivity

Overview

Product nameSARS-COV-2 Neutralizing Antibody
Catalog No.A19215
DescriptionSARS-COV-2 Neutralizing Antibody is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293). This antibody recognizes the SARS-CoV-2 Spike Protein RBD domain and inhibits the interaction between SARS-CoV-2 RBD and ACE2 with an IC50 of 0.496 μg/mL using SARS-CoV-2 Inhibitor Screening Kit(Cat.No.RK04149).
SourceHuman
Affinity purification byProtein A
IsotypeHuman IgG1
Concentration1mg/mL
Purity>95% by SDS-PAGE.
Endotoxin< 0.1 EU/μg of the protein by LAL method.
FormulationLyophilized from a 0.22 μm filtered solution of PBS, pH 7.2, with 10% Trehalose.
StorageStore the lyophilized protein at -20°C to -80 °C for long term.
Avoid repeated freeze/thaw cycles.
ABclonal:SDS-PAGE}

SDS-PAGE

Immobilized SARS-CoV-2 S1 protein, His Tag (Cat. No. RP01262) at 1 μg/mL (100μL/well) can bind Anti-SARS-CoV-2 Neutralizing Antibody, Human IgG1 (Cat. No. A19215) with a linear range of 0.078-5 ng/mL
ABclonal:Bioactivity}

Bioactivity

Serial dilutions of Anti-SARS-CoV-2 Neutralizing Antibody, Human IgG1 (Cat.No. A19215) was detected by SARS-CoV-2 Inhibitor screening Kit (Cat.No. RK04149) with a half maximal inhibitory concentration (IC50) of 0.496ug/mL.

Inquire About This Product

Submit your question about A19215 below and we will get back to you within one business day.

Alternatively, call us at 888.754.5670.

Select size and quantity
Contact us to order